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Background: Understanding the prevalence of type 2 diabetes in Nepal can help in planning for health
services and recognising risk factors. This review aims to systematically identify and collate studies describing
the prevalence of type 2 diabetes, to summarise the findings, and to explore selected factors that may influence
prevalence estimates.
Design: This systematic review was conducted in adherence to the MOOSE Guidelines for Meta-Analysis
and Systematic Reviews of Observational Studies. Medical Literature Analysis and Retrieval System
(MEDLINE) database from 1 January 2000 to 31 December 2014 was searched for the prevalence of type 2
diabetes among Nepalese populations with a combination of search terms. We exploded the search terms to
include all possible synonyms and spellings obtained in the search strategy. Additionally, we performed a
manual search for other articles and references of published articles.
Results: We found 65 articles; 10 studies fulfilled the inclusion criteria and were included in the analyses.
These 10 studies comprised a total of 30,218 subjects. The sample size ranged from 489 to 14,009. All the
studies used participants older than age 15, of whom 41.5% were male and 58.5% female. All the studies were
cross-sectional and two were hospital-based. Prevalence of type 2 diabetes ranged from a minimum of 1.4% to
a maximum of 19.0% and pooled prevalence of type 2 diabetes was 8.4% (95% CI: 6.210.5%). Prevalence of
type 2 diabetes in urban and rural populations was 8.1% (95% CI: 7.38.9%) and 1.0% (95% CI: 0.71.3%),
respectively.
Conclusions: This is, to our knowledge, the first study to systematically evaluate the literature of prevalence of
type 2 diabetes in Nepal. Results showed that type 2 diabetes is currently a high-burden disease in Nepal,
suggesting a possible area to deliberately expand preventive interventions as well as efforts to control the
disease.
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A
pproximately 387 million people are living with
diabetes worldwide with an estimated prevalence
of 8.3% in 2014 and is predicted to increase to
10% by 2030 (1). Diabetes caused 4.9 million deaths in
2014, costing 612 billion dollars in health care (1). More
than 80% of diabetes deaths are reported in low- and
middle-income countries (LMICs) (2). Of the two
forms of diabetes, type 2 diabetes is widespread globally,
accounting for over 90% of all diabetes cases (2). A
systematic review carried out in 2012 confirmed a rapid
increase in prevalence over the last two decades in the
South Asian region (3). The prevalence of type 2 diabetes
in South Asia in 2011, according to the International
Diabetes Federation (IDF), is shown in Fig. 1 (4).
Factors such as family history, urban residence, advanced
age, higher Body Mass Index (BMI), poor lifestyle, and
hypertension were found to be major drivers behind the
increasing prevalence of diabetes in South Asia (3).
Nepal is passing through a phase of epidemiological
transition from a higher prevalence of communicable dis-
eases to that of non-communicable diseases (NCDs) and
is currently suffering from a double burden of diseases (5).
The prevalence of NCDs including type 2 diabetes is
expected to increase rapidly in the near future (6). There
is a lack of reliable and representative data on the pre-
valence of type 2 diabetes in Nepal. Various small studies
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from different parts of the country carried out on the
diverse populations have shown varying prevalence rates
ranging from 6.3 to 8.5% (7, 8). Individually these studies
cannot provide sufficient information about the overall
prevalence of type 2 diabetes in the country due to the
non-representativeness of the study populations. It is
anticipated that bringing together the currently available
evidence on the prevalence of type 2 diabetes in Nepal
will improve statistical power and provide more accurate
estimations to inform policy makers at the local and
national level to control the emerging burden of the
disease. Thus, the purpose of this review is to document
the studies estimating the prevalence of and associated
risk factors of type 2 diabetes in Nepal through a sys-
tematic review and meta-analysis.
Methods
Data selection
This systematic review was conducted in adherence to the
MOOSE Guidelines for Meta-Analysis and Systematic
Reviews of Observational Studies (9). Data on the pre-
valence of diabetes among the Nepalese adults were
obtained by a three-stage process. In the first stage, a
search of the online Medical Literature Analysis and
Retrieval System (MEDLINE) database was performed
with a combination of Medical Subject Headings (MeSH)
terms: ‘Diabetes Mellitus’ as the MeSH major topic and
‘Epidemiology/EP’ as the MeSH subheading. We ex-
plored the search terms to include all possible synonyms
and spellings obtained in the search strategy. We did not
use pre-diabetes as a MeSH term since this search term
was only introduced in 2002 and definitions of pre-
diabetes cannot be found from studies predating 2002.
The search limits were language (‘English’), dates (between
‘1st January 2000’ and ‘31st December 2014’), and species
(‘Human’). In addition, the above results were narrowed
down by adding ‘Nepal’ as a key word. Two researchers
(BG, RS) independently searched the database with these
search terms to ensure that none of the relevant studies
were missed. Additionally, we performed a manual search
for other articles and references of published articles.
We identified a number of studies from World Health
Organization (WHO) publications (one study) (10), grey
literature (two studies) (11, 12), university institutional
website (one study) (13), and reference lists of retrieved
articles (three studies) (1416). We attempted to retrieve
grey literature through Google. One email request was
also sent to a corresponding author to obtain raw data
(15), but the attempt was unsuccessful. Since the reported
prevalence rate was unusually high, the article was ex-
cluded from the analysis, which we believe was the
appropriate action.
In the second stage, the total hits obtained from
MEDLINE using the above criteria were screened by
reading titles and abstracts. Studies not satisfying the
inclusion criteria were excluded. The studies identified for
inclusion in the second stage were further screened for
suitability during the third stage by reading the selected
manuscripts. As a part of our search strategy, we in-
cluded studies only if they met the following criteria:
1) population-based cross-sectional studies reporting the
prevalence of type 2 diabetes and published in English;
2) the studies were conducted in Nepal after 2000 and
published between 1 January 2000 and 31 December 2014;
3) the study subjects being 15 years and above, including
both men and women and not restricted to a specific
profession; 4) with information on the survey year, popu-
lation characteristics, age group, sample size of both men
Fig. 1. Prevalence of type 2 diabetes in South Asia. Source: International Diabetes Federation, 2012.
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and women, survey procedure, and diagnostic criteria;
5) studies consisting primary data; and 6) studies that
defined type 2 diabetes using the WHO, American Dia-
betes Association (ADA), or both. When there was more
than one report relating to the same study sample, the
most up-to-date and relevant study was included. All
studies were original and contained a minimum of infor-
mation necessary to calculate pooled analysis of pre-
valence (number of subjects and number of diabetes
events). The full text of studies meeting inclusion criteria
was retrieved and screened to determine eligibility by two
reviewers (BG, RS).
Data extraction
For each eligible study, we extracted the following data by
means of a structured data extraction form: first author,
year of publication, study design, sampling method,
urban/rural residence, net sample size (number of in-
cluded men and women separately), age range, prevalence
of pre-diabetes and diabetes, diagnostic method, diag-
nostic criteria, and reagent used. Where available, odds
ratios (ORs) with respective confidence interval (CI) for
associated risk factors (gender, age, BMI, family history,
physical activity levels, the area of residence, and hyper-
tension) were recorded.
We entered data in a pre-tested Microsoft Office
Excel spreadsheet designed based on the Strengthening
the Reporting of Observational Studies in Epidemiology
Statement (STROBE) checklist (17). We performed qua-
lity assessment of included studies to determine the poten-
tial for selection bias based on the presence of eligibility
criteria, sampling strategy, sample size, non-response
rate, explaining limitations of the study, and generalisa-
bility as well as for measurement bias which included
measurement techniques (18). These two biases are im-
portant in cross-sectional studies that aim to estimate
prevalence. A total of 11 domains were assessed. A score
of one was given for fulfilling conditions in each domain,
0.5 for partial fulfilment, and 0 otherwise. The maximum
possible score was 11 and a study scoring seven or more
was classified as a high-quality study and low-quality
study otherwise. Each study was rated and the quality of
the study has been included in the ‘study characteristics’
table (Table 1). Three studies fulfilled the highest quality
criteria (10, 23, 25), while the majority of the articles did
not include the limitations of the studies. The detailed
inclusion and exclusion criteria as well as extraction
process of the articles are shown in Fig. 2.
Study characteristics
Ten studies that fulfilled the inclusion criteria were used
for the review (8, 10, 1926). Publication years ranged
from 2000 to 2014. These 10 cross-sectional studies com-
prised a total sample size of 30,218. The sample size
ranged from 489 to 14,009. All the studies used partici-
pants older than age 15, comprising 41.5% males and
58.5% females. All of the studies were cross-sectional and
two were hospital-based (19, 20). Three studies reported
their sampling methods (10, 23, 25): one used simple
random sampling (25), one used cluster sampling (23),
and the third used probability proportionate to size (10).
Three studies reported response rates (10, 23, 25). Five
studies reported using fasting plasma glucose (FPG) as
the diagnostic method of type 2 diabetes (8, 10, 21, 24, 25):
three studies reported both FPG and oral glucose
tolerance test (OGTT) (19, 20, 23), one used FPG/urine
(26), and one reported OGTT (22). All studies used
glucose oxidase/peroxidase for the determination of
free glucose in body fluids. Three studies classified urban
and rural prevalence of diabetes separately (10, 21, 25).
The reported prevalence rates in urban areas were 19.4,
14.6, and 1.4% and in rural areas were 1.3, 2.5, and
0.03%. Studies did not present prevalence rates based on
gender, age, and other factors. We could only gather ORs
based on those factors. Information regarding prevalence
rates based on residence (rural/urban) was present in only
three of the studies and we concluded that this stratifi-
cation would provide some information regarding the
distribution of type 2 diabetes. However, the table has not
been included in this article. One study used the 1985
WHO diagnostic criteria for diabetes which included the
cut-off point for FPG as greater than 7.8 mmol/L (19).
The characteristic of studies included in this review is
shown in Table 1.
The diagnostic criteria for the presence of ‘type 2
diabetes mellitus’ used in eligible studies were the 1985
criteria from WHO (27), the 1999 WHO criteria (28), the
1997 criteria from the ADA (28), or its updates (29, 30).
‘Pre-diabetes’ was defined as the presence of impaired
fasting glucose (IFG) or impaired glucose tolerance (IGT)
based on FPG level 6.16.9 mmol/l (110125 mg/dl)
or fasting glucose measurement less than 7.0 mmol/l
(up to 126 mg/dl). ‘Diabetes mellitus’ was defined based
on fasting glucose level greater or equal to 7.0 mmol/l
(126 mg/dl) or greater. Values for diagnosis of type 2
diabetes by WHO and ADA are shown in Table 2.
Statistical analysis
We performed meta-analysis using STATA version 12
(StataCorp, College Station, TX, USA). We calculated
pooled prevalence estimates and 95% CIs by meta-
analysis. The pooled prevalence was calculated by using
standard error of prevalence that is given by [p(1
p)/n], where p is the proportion of prevalence and n is the
reported sample size. Heterogeneity among studies was
assessed with the Cochran chi-square (x2) and quantified
with the I2 and tau-square (t2) and the values have been
mentioned in the text (31). I2 is the proportion of total
variation provided by between-study variation, and I2
values of 0, 25, 50, and 75% represent no, low, moderate,
and high heterogeneity, respectively (32). t2 is a method
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Table 1. Study characteristics
Prevalence
Study ID
Year of
publication Study design
Sampling
method
Sample size
(male/female) Urban/rural
Age
group
Pre-
diabetes
Type 2
diabetes
Diagnostic
method
Diagnostic
criteria Reagent used Quality
Baral N (19) 2000 Hospital-based
cross-sectional
NR* 920 (487/433) Urban 3065 9.5 5.2 FPG/OGTT WHO 1998 Glucose oxidase/
peroxidase
Low
Karki P (20) 2000 Hospital-based
cross-sectional
NR 1,840 (1,040/800) Urban 30 NR 6.3 FPG/OGTT WHO 1985 Glucose oxidase/
peroxidase
Low
Singh DL (21) 2003 Cross-sectional NR 1,841 (856/985) Urban and
rural
]20 9.1 14.6 FPG WHO 1998,
ADA 1997
NR Low
Sasaki H (22) 2004 Cross-sectional NR 489 (161/328) Semiurban
and rural
20 2.5 1.4 OGTT WHO 1998,
ADA 1997
Glucose oxidase/
peroxidase
Low
Shrestha UK
(23)
2006 Cross-sectional Cluster 1,012 (423/589) Urban ]40 11.5 19.0 FPG/OGTT WHO 1998,
ADA 1997
Glucose oxidase/
peroxidase
High
Ono K (24) 2007 Cross-sectional NR 740 (286/454) Semiurban 20 19.2 9.5 FPG NR NR Low
Mehta KD
(25)
2011 Cross-sectional Simple random 2,006 (1,096/910) Urban and
rural
]30 16.9 11.9 FPG WHO 1998 Glucose oxidase/
peroxidase
High
Sharma SK
(8)
2011 Cross-sectional NR 14,009 (5,327/8,682) Rural ]20 NR 6.3 FPG IDF 2009 Glucose oxidase/
peroxidase
Low
Sharma SK
(26)
2013 Cross-sectional NR 3,218 (1,542/1,676) Rural ]20 NR 7.5 FPG/Urine ADA 2003 Glucose oxidase/
peroxidase
Low
Aryal KK (10) 2013 Cross-sectional Probability
proportionate to
size
4,143 (1,336/2,807) Urban and
rural
1569 4.1 3.6 FPG WHO 2005 Glucose oxidase/
peroxidase
High
*NRnot recorded.
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of moment estimate of between-study variance (33).
The rural and urban categories were made based on
the information provided by the individual studies. We
evaluated potential risk factors for the prevalence of
diabetes by meta-analysis. We used two formal tests:
Begg’s adjusted-rank correlation test (34) and Egger’s
regression asymmetry test (35) to evaluate publication
bias quantitatively.
Random effects model was carried out to address
heterogeneity in the pooled proportions (PB0.05 from x2
test) (36). The random effects model assumes that the
observed heterogeneity is determined by real differences
in the distribution. The model calculated pooled pre-
valence and 95% CIs. A low P value or large chi-squared
statistic (relative to its degree of freedom) suggests hetero-
geneity and variation in effect estimates beyond chance.
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58 records identified through
database searching and 7 records
identified through additional
sources
Articles for screening (n=65)
Abstracts retained for a detailed
assessment (n=44) 
Studies included for analysis
(n=10)
Excluded records (n=21)
Reasons for exclusion:
Identified as not potentially
relevant, case reports, reviews, or
editorials   
Excluded records (n=34)
Not prevalence studies=24
No original data=4
Multiple reports of the same result=2
One gender study=2
Study among specific population=1
No clear prevalence information=1
Fig. 2. Flow diagram of study.
Table 2. Values for diagnosis of type 2 diabetes by WHO and ADA
Glucose concentrations, mmol/L (mg/dL)
Whole blood Plasma
Venous Capillary Venous
Type 2 diabetes (WHO 1985)
Fasting 6.1 (110) 6.1 (110) 7.8 (140)
2-hour post-glucose load or both 10.0 (180) 11.1 (200) 11.1 (200)
Type 2 diabetes (ADA 1997, 2003; WHO 1999)
Fasting 6.1 (110) 6.1 (110) 7.0 (126)
2-hour post-glucose load or both 10.0 (180) 11.1 (200) 11.1 (200)
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A two-tailed P value B0.05 was considered statistically
significant in all analyses.
Ethical consideration
This article is based on published data, and hence ethical
approval is not required.
Results
Prevalence of type 2 diabetes
The estimated pooled prevalence of type 2 diabetes in
Nepal was 8.4% (95% CI: 6.210.5%). We observed
a high degree of heterogeneity (I298.0%; t211.26;
PB0.001), with prevalence rates ranging from 1.4 to
19.0%. Figure 3 represents a meta-analysis of studies that
measured the prevalence of type 2 diabetes in Nepal.
Significant differences in type 2 diabetes prevalence were
observed between urban and rural parts of Nepal. The
pooled urban prevalence of type 2 diabetes was 8.1%
(95% CI: 7.38.9%; I299.5%; PB0.001) and rural
prevalence of type 2 diabetes was 1.0% (95% CI: 0.7
1.3%; I294.2%; PB0.001). Seven studies reported the
prevalence of pre-diabetes (10, 1923, 26). The overall
prevalence of pre-diabetes was found to be 10.3% (95%
CI: 6.114.4%; t230.43, I298.4%; PB0.001).
Risk factors of type 2 diabetes
Meta-analysis was performed and pooled ORs were
calculated from the adjusted ORs and 95% CI in each
available study. The pooled OR from random effect
analysis showed that the likelihood of having type 2
diabetes was higher among females (OR1.6; 95% CI:
1.31.9; I287.2%, PB0.05) (8, 10, 21, 23, 25, 26). We
found pooled OR for increasing age to be 1.05 (95% CI:
1.041.05; I248.0%; P0.05) (8, 21, 23, 26) and pooled
OR for hypertension to be 2.16 (95% CI: 1.52.8: I20.0%;
P0.05) (23, 25). One study reported urban residency,
having a higher socio-economic status and a higher BMI
as risk factors for diabetes (25). One study reported
physical activity and primary education as risk factors for
diabetes (8). We could not conduct a meta-analysis and
calculate pooled ORs of these studies since only one
study reported the same risk factor.
Publication bias
The results of the statistical test for publication bias,
including Begg’s adjusted-rank correlation test and
Egger’s regression asymmetry test were statistically insig-
nificant (P0.060 and P0.086, respectively). These
results showed no evidence of publication bias. Even
if these tests are negative, there is still a possibility of
publication bias. Figure 4 represents the funnel plot for
Fig. 3. Prevalence of type 2 diabetes in Nepal.
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visualising publication bias amongst the 10 studies used
for meta-analysis.
Discussion
This is the first study, to our knowledge, to systematically
evaluate the literature of prevalence of type 2 diabetes
in Nepal. This study summarised prevalence of type 2
diabetes in Nepal for a 14-year period (20002014). The
pooled prevalence of type 2 diabetes was found to be
8.4% (95% CI: 6.210.5%)  higher than the current
national estimate of 4.5% (4). However, this pooled result
is consistent with other literature examining the preva-
lence of type 2 diabetes in different parts of the world.
For instance, prevalence based on the most recent na-
tional surveys in neighbouring countries of Nepal that
have similar culture and lifestyle profiles (37) were 8.5%
in India, 6.7% in Pakistan, and 8% in Sri Lanka ac-
cording to IDF estimates 2012 (4). Moreover, our study
reported the estimates ranged from 1.4 up to 19.0%. This
is comparable to the wide range of prevalence rates
obtained from a review by Siddiqui and colleagues, which
showed prevalence rates of diabetes varying between 0.9
and 21.2% in Bangladesh and India, respectively (38). A
Mexican study reported a prevalence of diabetes ranging
from around 3 to 20% (39). Various socio-economic
characteristics and lifestyle behaviours of rural and urban
regions may have attributed to these observed differences
between regions. The reported high prevalence of dia-
betes exemplifies the shift from a burden of disease ruled
by mortality from infectious causes to chronic ones (40).
This increase could be attributed to various lifestyle
changes associated with urbanisation and deterioration
of the ecological environment (41). Linking to increase in
obesity and reduction in physical activities in recent years
in Nepal (6, 42), the prevalence of pre-diabetes 10.3%
(95% CI: 6.114.4%) observed in this study further
highlights a potential indicator of further progression of
the epidemic in the country unless preventive measures
are introduced at a large scale.
In this review, we found that the pooled prevalence of
diabetes was 8.1% (95% CI: 7.38.9%) for urban popula-
tions and 1.03% (95% CI: 0.71.3%) for rural popula-
tions. A wealth of studies has reported that the problem
of diabetes is largely concentrated in urban areas (43, 44).
Few population-based studies conducted in Nepal so far
have reported a high prevalence of type 2 diabetes in
urban areas (21, 23). For instance, in a study by Singh
et al. the prevalence of type 2 diabetes in an urban area of
Nepal was 14.6% compared to 2.5% in a rural area (21).
There is an increasing urbanisation in Nepal (45). The
general shift of people from rural to urban areas for
education, employment, and a better life may have
contributed to an increasing burden of type 2 diabetes.
It is also possible that people with diabetes may move to
urban areas after diagnosis to be closer to hospitals,
perhaps staying with urban family members.
This review found that being a woman is a significant
risk factor for diabetes in Nepal. There is a paucity
of Nepal-specific studies depicting high risk of type 2
diabetes among women; however, a systematic review
from India reported that women are at higher risk of
type 2 diabetes (46). The positive association we found
between gender and type 2 diabetes has also been ob-
served in Pakistan (47) and Turkey (48). One possible
reason behind this might be due to low educational
level of women as a result of which they might pay
less attention to their dietary intake habits and physical
activities. One statistic puts female literacy rate at around
47% as compared to 71% for men in Nepal (45). Moreover,
owing to patriarchal mindset, women are normally
expected to pay more attention to the health of the
men and children in the family, and in the process they
might ignore their own well-being (49). A wealth of
studies has documented an association between diabetes
and BMI (50), family history (51), physical inactivity
(52), and area of residence (53). We could not perform a
meta-analysis for these risk factors due to the limited
number of studies in Nepal. More studies are needed to
explore the association between diabetes and its risk
factors in Nepalese settings.
Given the considerable burden of diabetes, there is a
need for future research efforts focusing on preven-
tive interventions and control measures in the Nepalese
communities. It is necessary to consider the development
of cost-effective intervention methods for diabetes pre-
vention and control such as routine diabetes care includ-
ing lifestyle counselling, early screening, monitoring of
hyperglycaemia, provision of diabetes education, and self-
management care programs (54, 55). At present, the gov-
ernment and few non-government organisations (NGOs)
are conducting few awareness creation programs on the
prevention of type 2 diabetes through health camps and
Fig. 4. Funnel plot with 95% confidence limits showing the
prevalence (p) of type 2 diabetes in each study by the
standard error (s.e.) of the studies.
Type 2 diabetes prevalence in Nepal
Citation: Glob Health Action 2015, 8: 29088 - http://dx.doi.org/10.3402/gha.v8.29088 7
(page number not for citation purpose)
by using the mass media in Nepal (56). However, diabetes
and other NCDs are still not the priority area of the
government and there is a paucity of programs to detect,
manage, and prevent diabetes and NCDs in the country
(57). Moreover, the level of knowledge, attitude, and
good practice as a means to control and prevent diabetes
is very low among Nepali people (20). Unless urgent and
specific focus is on preventing, treating, and controlling
of diabetes, the burden of diabetes will be severe in low-
resource setting such as Nepal. Acquiring information
regarding awareness level about diabetes is the first step
in formulating prevention programs for diabetes (51).
Therefore, a national strategy is required to address the
disease burden and one of the strategies would be to
involve a large number of community health care workers
to communicate with the general public at large which
can serve as an antecedent for future prevention and
management efforts of type 2 diabetes in low-resource
settings (58). Furthermore, information on the preven-
tion and control of diabetes must be incorporated into
general health promotion programs, from the govern-
ment, NGOs and international non-government organi-
sations (INGOs). Specific lifestyle interventions tailored
to meet the cultural, religious, and socio-economic needs
of the target communities are urgently needed.
Limitations
This study has some limitations, which are noteworthy.
Our study is limited only to the selected database source
and English-language publications and therefore might
have missed a small number of relevant publications.
Considering the very low number of eligible articles, we
took diabetes studies regardless of the place of study. We
could not consider key variables that have shown to
influence the prevalence of diabetes in this study such as
BMI, family history, physical activity, and diet intake.
More than two-thirds of studies included were of poor
methodological quality in terms of sample size, variable
selection, and sampling techniques, which might have
resulted in some bias. Overall, a high degree of hetero-
geneity was observed in the included studies. Three
articles fulfilled the criteria for reporting high-quality
studies. The majority of the articles lacked the limitations
of their studies. Two of the studies were hospital-based
(19, 20), we considered removing those as they are not
typical general population studies. However, the preva-
lence rates in those two studies (5.2 and 6.3%) were at the
lower end of the range (one would expect a much higher
prevalence in the hospital). These two hospital-based
studies may have biased the urbanrural difference as
hospitals in Nepal are based in urban areas but provide
care for both urban and rural patients.
Conclusions
Our pooled results support the finding that type 2 dia-
betes is currently a high-burden disease in Nepal suggest-
ing a possible area for health promotion activities as well
as early diabetes interventions to help control the disease.
Further prevalence studies are needed with a robust
method. In spite of the limited publications, our review
suggests that there are considerable differences in the
prevalence of type 2 diabetes between rural and urban
areas and between studies. Consequently, there is a need
to prioritise diabetes on the public health care agenda
in Nepal through the promotion of preventive measures
such as dietary pattern, exercises, and periodic check-up.
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